Table 2 Cox Proportional Hazards Regression Analyses of overall survival for ENB patients in the training Cohort
From: A novel nomogram to predict the overall survival in esthesinoeroblastoma
Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
HR (95%) | P | HR (95%) | P | |
Sex (%) | Ref | |||
Female | 1.392 (0.826–2.344) | 0.214 | NI | |
Male | NI | |||
Age(%) | ||||
< =54 | Ref | Ref | ||
55–69 | 1.787 (1.002–3.186) | 0.049 | 1.726 (0.962–3.097) | 0.067 |
> =70 | 4.131 (2.160–7.900) | < 0.001 | 3.773 (1.950–7.505) | < 0.001 |
Tumor Grade(%) | ||||
Low | Ref | Ref | ||
High | 2.240 (1.354–3.707) | < 0.001 | 1.991 (1.151–3.444) | 0.014 |
Modified Kadish | ||||
A or B | Ref | Ref | ||
C | 2.536 (1.187–5.42) | 0.016 | 1.950 (0.892–4.263) | 0.094 |
D | 5.246 (2.199–12.51) | < 0.001 | 2.797 (1.057–7.401) | 0.038 |
Chemotherapy | ||||
N | Ref | Ref | ||
Y | 1.857 (1.126–3.061) | 0.015 | 1.161 (0.635–2.122) | 0.628 |
Radiotherapy | ||||
N | Ref | NI | ||
Y | 0.725 (0.435–1.209) | 0.218 | NI | |
Surgery | ||||
N | Ref | Ref | ||
Y | 0.407(0.217–0.764) | 0.005 | 0.729 (0.362–1.470) | 0.378 |